Curriculum Vitae - Ara Vaporciyan, M.D.

---

Academic and Professional Appointments:

2002-present, Director, Cardiac & Vascular Surgical Oncology Program, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

1998 - present, Assistant Professor and Assistant Surgeon, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Back to Top

---

Editorships and Editorial Board Memberships:

Adhoc reviews:

• Asian Cardiovascular & Thoracic Annals, 2000

Back to Top

---

Lectureships and Visiting Professorships:

Back to Top

---

Honors and Awards:

• Outstanding Surgical Resident Award, The University of Texas, M. D. Anderson Cancer Center, 1996

Back to Top

---

Society Memberships and Offices Held:

• Member, Southern Thoracic Surgical Association, 2001-Present
• Candidate, Society of Thoracic Surgeons, 2000-Present
• Member, American Thoracic Society, 1999-Present
• Member, Cooley Hands, 1998-Present
• Member, Denton A Cooley Cardiovascular Surgical Society, 1996-Present

Back to Top

Bibliography:

Published and accepted articles in refereed journals

Published and accepted invited journal articles

Published and accepted book chapters

Back to Top

---

Institutional Service Responsibilities and Other Duties:

Alternate Member,Medical Practice Subcommittee 2001 - present

Member, Medical Records Subcommittee, 2001 - present

Back to Top

---

Formal Teaching Experience:

Courses taught:

• PECAM-1 (CD31, endoCAM) is involved in neutrophil recruitment in vivo, Trauma and Immune Consequences, Munich, Germany, 4/94.
• Research during surgical residency, The University of Texas Medical School-Houston, General Surgery Pathophysiology Lecture, 9/98.
• Multimodality therapy in esophageal cancer, Baylor College of Medicine, Pathophysiology Lecture Series, 10/98.
• Surgical treatment in lung cancer: examining the role of multimodality therapy, Grand Rounds, Methodist Hospital Cancer Center, Lubbock, TX, 3/00.
• Multi-modality approach to non-small cell lung cancer, Grand Rounds, Bristol-Myers Squibb, Texas Tech Health Science Center, Lubbock, TX, 6/00.
• The surgical management of lung cancer". Oncology Visiting Faculty Program, Christus St. Francis Cabrini Hospital, Alexandria, LA , 6/00.
• Innovative multidisciplinary approaches for lung cancer, Grand Rounds, McLaren Regional Medical Center, Flint, MI, 9/00.
• Surgical treatment of lung cancer, Surgical Oncology Fellows Conference, The University of Texas - M. D. Anderson Cancer Center, Houston, TX, 11/00.
• Early detection and multi-modality treatment of lung cancer, Bristol-Myers Squibb Oncology Visiting Faculty Program, Le Lavandier, Macon, GA, 12/00.
• Isolated pulmonary nodules: management and intra-operative decision making, Advances in Oncology Institutional Grand Rounds, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 12/00.
• Atelectasis/postoperative atelectasis and pleural effusion, Presented to the Department of Coding, The University of Texas M. D. Anderson Cancer Center, Houston, TX 04/01.
• Chapter 33-34 of Glenn's Textbook, Chest Wall Abnormalities, Chest Wall Tumors, Baylor Cardiothoracic Surgery Lecture Series, Houston, Texas 12/01.
• Lung cancer screening, Surgical Oncology Fellows Conference, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 01/02.
• Rodent model of post-operative lung injury, Lung Injury Study Group, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 3/02.

Back to Top

---

Invitations to National or International Conferences:

1. Rapid determination of neutrophil/endothelial adhesions in vitro using fluorescent labeling of cells, FASEB, 4/92.
2. Impact of operative volume on morbidity, mortality and hospital usage following esophagectomy for esophageal cancer, Western Thoracic Surgical Association, Olympic Valley, CA, 6/99.
3. Characterization of acute lung injury after isolated lung perfusion with doxorubicin, ACCP, American College of Chest Physician, San Francisco, CA, 10/00.
4. Impact of timing of smoking cessation on pulmonary morbidity after pneumonectomy. 47th Annual Meeting of the Southern Thoracic Surgical Association, Marco Island, FL, 11/00.
5. Early screening techniques for lung cancer. 1st Annual Oncology Update: Advances and Controversies, Steamboat Springs, CO, 2/01.
6. Use of cardiopulmonary bypass for resection of advanced cardiothoracic malignancies. 15th Annual Meeting of the European Association for Cardio-Thoracic Surgeons, Lisbon, Portugal, 09/01.
7. Neutrophil depletion reduces lung injury after iIsolated lung perfusion for pulmonary metastasis. 87th Clinical Congress of the American College of Surgeons, New Orleans, LA, 10/01.
8. Perfluorocarbon improves adenoviral-mediated transfection of lung cancer cell lines via cell mediated effects. 2001 AACR-NCI-EORTC International Conference on Molecular Cancer Therapeutics, Miami Beach, FL, 11/01.
9. Current advances in lung and esophageal cancer. Congress of the Slovenian Association of Surgeons, Hoteli Marje, Portorož, 05/02.

Back to Top

Other Activities:

Local presentations:

 

Back to Top